RIN2 Activators
RIN2 Activators are chemicals that can indirectly influence the activity of RIN2, a protein involved in endocytosis and Rab5 regulation. These substances typically function by modulating various aspects of the endocytic pathway, thus influencing RIN2's role as a guanine nucleotide exchange factor (GEF) for the small GTPase Rab5. For instance, EGF can stimulate endocytosis, potentially increasing the demand for RIN2's GEF activity. Wortmannin and LY294002, both PI3K inhibitors, as well as rapamycin, an mTOR inhibitor, can affect endosomal trafficking and fusion, thereby potentially influencing RIN2's role in these processes.
On the other hand, Bafilomycin A1, Monensin, Dynasore, Pitstop 2, Genistein, Chlorpromazine, MβCD, and Nystatin can all disrupt different aspects of endocytic trafficking and endosome formation, thereby indirectly influencing RIN2. For example, Bafilomycin A1 inhibits endosome acidification, potentially increasing the demand for RIN2's role in Rab5-mediated endosome fusion. Similarly, Genistein, a tyrosine kinase inhibitor, can affect endocytic trafficking, potentially altering the demand for RIN2's GEF activity.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor. mTOR regulation can indirectly affect endosomal trafficking and potentially influence RIN2-mediated Rab5 activation. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
Bafilomycin A1 is a specific inhibitor of vacuolar-type H+-ATPase (V-ATPase). By inhibiting endosome acidification, it could potentially increase RIN2's role in facilitating Rab5-mediated early endosome fusion. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
Monensin is a sodium ionophore that disrupts endosomal ion homeostasis, potentially leading to an increased demand for RIN2's GEF activity for Rab5. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
Dynasore is a non-competitive inhibitor of dynamin, which can indirectly influence RIN2 activity by disrupting endocytic vesicle formation. | ||||||
Pitstop 2 | 1419320-73-2 | sc-507418 | 10 mg | $360.00 | ||
Pitstop 2 is a selective inhibitor of clathrin-mediated endocytosis, indirectly influencing RIN2 activity by disrupting the formation of early endosomes. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a broad-spectrum tyrosine kinase inhibitor that can indirectly affect RIN2 by influencing endocytic trafficking. | ||||||
Chlorpromazine | 50-53-3 | sc-357313 sc-357313A | 5 g 25 g | $61.00 $110.00 | 21 | |
Chlorpromazine interferes with clathrin-mediated endocytosis and can indirectly influence RIN2 activity. | ||||||
Methyl-β-cyclodextrin | 128446-36-6 | sc-215379A sc-215379 sc-215379C sc-215379B | 100 mg 1 g 10 g 5 g | $20.00 $48.00 $160.00 $82.00 | 19 | |
Methyl-β-cyclodextrin (MβCD) depletes cholesterol from the plasma membrane, affecting lipid raft-dependent endocytosis and potentially influencing RIN2's role in Rab5-mediated endosome fusion. | ||||||
Nystatin | 1400-61-9 | sc-212431 sc-212431A sc-212431B sc-212431C | 5 MU 25 MU 250 MU 5000 MU | $51.00 $129.00 $251.00 $3570.00 | 7 | |
Nystatin is a polyene antibiotic that alters membrane cholesterol distribution, influencing lipid raft-dependent endocytosis and potentially affecting RIN2's role in Rab5-mediated endosome fusion. | ||||||